Neuroendocrine-immune system interactions and autoimmunity

Annual Review of Immunology

Volumn 13, Issue , 1995, Pages 307-338

  Wilder, Ronald L ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

corticosteroids; hypothalamic pituitary adrenal axis; hypothalamic pituitary gonadal axis; stress response; thymus

Indexed keywords

CORTICOSTEROID; CYTOKINE; GONADORELIN; INTERLEUKIN 1; INTERLEUKIN 6; SEX HORMONE;

AUTOIMMUNITY; DIABETES MELLITUS; ETIOLOGY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMUS;

EID: 0028933798     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.iy.13.040195.001515     Document Type: Review

References (220)

1. Blalock JE. 1989. A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol. Rev. 69:1-32
2. Bateman A, Singh A, Kral T, Solomon S. 1989. The immune-hypothalamic-pituitary-adrenal axis. Endocrine Rev. 10:92-112
3. Ader R, Felten DL, Cohen N, eds. 1991. Psychoneuroimmunology. San Diego, CA: Academic. 2nd ed.
4. Marchetti B, Morale MC, Batticane N, Gallo F, Farinella Z, Cioni M. 1991. Aging of the reproductive-neuroimmune axis. A crucial role for the hypothalamic neuropeptide luteinizing hormone-releasing hormone. Ann. N. Y. Acad. Sci. 62:159-73
5. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M. 1991. Sex steroids, glucocorticoids, stress and autoimmunity. J. Steroid Biochem. Mol. Biol. 40:619-37
6. Chrousos GP, Gold PW. 1992. The concepts of stress and stress system disorders. J. Am. Med. Assoc. 267:1244-52
7. Sternberg EM, Chrousos GP, Wilder RL, Gold PW. 1992. The stress response and the regulation of inflammatory disease. Ann. Intern. Med. 117:854-66
8. Goetzl EJ, Sreedharan SP. 1992. Mediators of communication and adaptation in the neuroendocrine and immune system. FASEB J. 6:2646-52
9. Berczi I, Baragar FD, Chalmers IM, Keystone EC, Nagy E, Warrington RJ. 1993. Hormones in self tolerance and autoimmunity: A role in the pathogenesis of rheumatoid arthritis. Autoimmunity 16:45-56
10. Reichlin S. 1993. Neuroendocrine-immune interactions. New Engl. J. Med. 329:1246-53
11. Rivier C, Rivest S. 1993. Mechanisms mediating the effects of cytokines on neuroendocrine functions in the rat. Ciba Found. Symp. 172:204-20
12. Stein M, Miller AH. 1993. Stress, the hypothalamic-pituitary-adrenal axis, and immune function. Adv. Exp. Med. Biol. 335:1-5
13. Wick G, Hu Y, Schwarz S. 1993. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocrine Rev. 14:539-63
14. Menzaghi F, Heinrichs SC, Pich EM, Weiss F, Koob GF. 1993. The role of limbic and hypothalamic corticotropin-releasing factor in behavioral responses to stress. Ann. N. Y. Acad. Sci. 697:142-54
15. Chrousos GP. 1992. Regulation and dysregulation of the hypothalamic-pituitary-adrenal axis. The corticotropin-releasing hormone perspective. Endocrinol. Metab. Clin. N. Am. 21:833-58
16. Valentino RJ, Foote SL, Page ME. 1993. The locus coeruleus as a site for integrating corticotropin-releasing factor and nor-adrenergic mediation of stress responses. Ann. N.Y. Acad. Sci. 697:173-88
17. Lyson K, McCann SM. 1993. Alphamelanocyte-stimulating hormone abolishes IL-1- and IL-6-induced corticotropin-releasing factor release from the hypothalamus in vitro. Neuroendocrinology 58:191-95
18. Grossman A, Costa A. 1993. The regulation of hypothalamic CRH. Impact of in vitro studies on the central control of the stress response. Funct. Neurol. 8:325-34
19. Stephanou A, Sarlis NJ, Knight RA, Lightman SL, Chowdrey HS. 1992. Glucocorticoid-mediated responses of plasma ACTH and anterior pituitary pro-opiomelanocortin, growth hormone and prolactin mRNA during adjuvant-induced arthritis in the rat. Neuroendocrinology 9:273-81
20. Reichlin S, Glaser RJ. 1958. Thyroid function in experimental streptococcal pneumonia in the rat. J. Exp. Med. 107:219-36
21. Vermeulen A. 1993. Environment, human reproduction, menopause, and andropause. Environ. Health Perspectives 101 (Suppl. 2):91-100
22. Rivier C, Rivest S. 1991. Effect of stress on the activity of the hypothalamic-pituitary-gonadal axis: peripheral and central mechanisms. Biol. Reprod. 45:523-32
23. Ferin M. 1993. Neuropeptides, the stress response, and the hypothalamic-pituitary-gonadal axis in the female rhesus monkey. Ann. N. Y. Acad. Sci. 697:106-16
24. Kamilaris TC, Debold CR, Johnson EO, Mamalaki E, Listwak SJ, Calogero AE, Kalogeras KT, Gold PW, Orth DN. 1991. Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats. Endocrinology 128:2567-76
25. Da Suva JA, Peers SH, Perretti M, Willoughby DA. 1993. Sex steroids affect glucocorticoid response to chronic inflammation and to interleukin-1. J. Endocrinol. 136:389-97
26. Spinedi E, Suescun MO, Hadid R, Daneva T, Gaillard RC. 1992, Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 131: 2430-36
27. Gallucci WT, Bum A, Laue L, Rabin DS, Chrousos GP, Gold PW, Kling MA. 1993. Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis. Health Psychol. 12:420-25
28. Vamvakopoulos NC, Chrousos GP. 1993. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction. J. Clin. Invest. 92:1896-1902
29. Jones TH, Kennedy RL. 1993. Cytokines and hypothalamic-pituitary function. Cytokine 5:531-38
30. Imura H, Fukata J-I. 1994. Endocrine-paracrine interactions in communication between the immune and endocrine systems. Activation of the hypothalamicpituitary-adrenal axis in inflammation. Eur. J. Endocrinol. 130:32-37
31. Besedovsky H, Del Rey A, Sorkin E, Dinarello CA. 1986. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 23:652-54
32. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. 1987. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522-24
33. Uehara A, Gottschall PE, Dahl RP, Arimura A. 1987. Interleukin-1 stimu-lates ACTH release by an indirect action which requires endogenous corticotropin-releasing factor. Endocrinology 121:1580-82
34. Breder CD, Dinarello CA, Saper C. 1988. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240:321-24
35. Bertini R, Bianci M, Ghezzi P. 1988. Adrenalectomy sensitizes mice to the lethal effects of interleukin-1 and tumor necrosis factor. J. Exp. Med. 167:1708-12
36. Ramachandra RN, Sehon AH, Berczi I. 1992. Neuro-hormonal host defence in endotoxin shock. Brain Behav. Immun. 6:157-69
37. Angeli A, Gatti G, Sartori ML, Masera RG. 1992. Chronobiological aspects of the neuroendocrine-immune network. Regulation of natural killer NK cell activity as a model. Chronobiologia 19:93-110
38. Cunningham ET Jr, De Souza EB. 1993. Interleukin 1 receptors in the brain and endocrine tissues. Immunol. Today 14:171-76
39. De Souza EB. 1993. Corticotropin-releasing factor and interleukin-1 receptors in the brain-endocrine-immune axis. Ann. N.Y. Acad. Sci. 697:9-27
40. Whitnall MH, Perlstein RS, Mougey EH. 1992. Effects of interleukin-1 on the stress-responsive and -nonresponsive subtypes of corticotropin-releasing hormone neurosecretory axons. Endocrinology 131:37-44
41. Payne LC, Weigent DA, Blalock JE. 1994. Induction of pituitary sensitivity to interleukin-1: a new function for corticotropin-releasing hormone. Biochem. Biophys. Res. Comm. 28:480-84
42. Koenig JJ, Snow W, Clark BD, Toni R, Cannon JG, Shaw AR, Dinarello CA, Reichlin S, Lee SL, Lechan RM. 1990. Intrinsic pituitary interleukin 1-β is induced by bacterial lipopolysaccharide. Endocrinology 126:3053-58
43. Andreis PG, Neri G, Belloni AS, Mazzocchi G, Kasprzak A, Nussdorfer GG. 1991. Interleukin-1 β enhances corticosterone secretion by acting directly on the rat adrenal gland. Endocrinology 129:53-57
44. Rivier C, Vale W. 1990. Cytokines act within brain to inhibit luteinizing hormone secretion and ovulation in the rat. Endocrinology 127:849-56
45. Rettori V, Gimeno MF, Karara A, Gonzalez MC, McCann SM. 1991. Interleukin 1 α inhibits prostaglandin E2 release to suppress pulsatile release of luteinizing hormone, but not follicle stimulating hormone. Proc. Natl. Acad. Sci. USA 88:2763-67
46. Dubuis JM, Dayer JM, Siegrist-Kaiser CA, Burger AG. 1988. Human recombinant interleukin-1 β decreases thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinology 123:2175-81
47. Kakucska I, Romero LI, Clark BD, Rondeel JMM, Qi Y, Alex S, Emerson CH, Lechan RM. 1994. Suppression of thyrotropin-releasing hormone gene expression by interleukin-1 -β in the rat: Implications for nonthyroidal illness. Neuroendocrinology 59:129-37
48. Saper CB, Breder CD. 1994. The neurologic basis of fever. New Engl. J. Med. 330:1880-86
49. Rothwell NJ. 1994. CNS regulation of thermogenesis. Crit. Rev. Neurobiol. 8:1-10
50. Tilders FJ, DeRijk RH, Van Dam AM, Vincent VA, Schotanus K, Persoons JH. 1994. Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxin: Routes and intermediate signals. Psychoneuroendocrinology 19:209-32
51. Kluger MJ. 1991. Fever: role of pyrogens and cryogens. Physiol. Rev. 71:93-127
52. Payne LC, Krueger JM. 1992. Interactions of cytokines with hypothalamus-pituitary axis. J. Immunotherapy 12:171-73
53. Payne LC, Obal R Jr. Krueger JM. 1993. Hypothalamic releasing hormones mediating the effects of interleukin-1 on sleep. J. Cell. Biochem. 53:309-13
54. Lechan RM, Toni R, Clark BD, Cannon JG, Shaw AR, Dinarello CA, Reichlin S. 1990. Immunoreactive interleukin-1 β localization in the rat forebrain. Brain Res. 514:135-40
55. Yao J, Keri JE, Taffs RE, Colton CA. 1992. Characterization of interleukin-1 production by microglia in culture. Brain Res. 591:88-93
56. Kakucska I, Qi Y, Clark BD, Lechan RM. 1993. Endotoxin-induced corticotropinreleasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1, Endocrinology 133:815-21
57. De Simoni MG, De Luigi A, Gemma L, Sironi M, Manfridi A, Ghezzi P. 1993. Modulation of systemic interleukin-6 induction by central interleukin-1. Am. J. Physiol. 265:R739-42
58. Licinio J, Wong M-L, Gold PW. 1991. Localization of interleukin-1 receptor antagonist mRNA in rat brain. Endocrinology 129:562-64
59. Naitoh Y, Fukata J, Tominaga T, Nakay Y, Tamai S, Mori K, Imura H. 1988. Interleukin-6 stimulates the secretion of adrenocorticotrophic hormone in conscious, free-moving rats. Biochem. Biophys. Res. Commun. 155:1459-63
60. Navarra P, Tsagarakis S, Faria MS, Rees LH, Besser GM, Grossman AB. 1990. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 128:37-44
61. Lyson K. McCann SM. 1992. Induction of adrenocorticotropic hormone release by interleukin-6 in vivo and in vitro. Ann. N.Y. Acad. Sci. 650:182-85
62. Klir JJ, Roth J, Szelenyi Z, McClellan JL, Kluger MJ. 1993. Role of hypothalamic interleukin-6 and tumor necrosis factor-α in LPS fever in rat. Am. J. Physiol. 265:R512-17
63. Schobitz B, Voorhuis DA, De Kloet ER. 1992. Localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Neurosci. Lett. 136:189-92
64. Schobitz B, de Kloet ER, Sutano W, Holsboer F. 1993. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur. J. Neurosci. 5:1426-35
65. Judd AM, Macleod RM. 1992. Adrenocorticotropin increases interleukin-6 release from rat adrenal zona glomerulosa cells. Endocrinology 130:1245-54
66. Muramami N, Fukata J, Tsukada J, Kobayashi H, Ebisui O, Segawa H, Muro S, Imura H, Nakao K. 1993. Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland and spleen. Endocrinology 133:2574-78
67. Brannstrom M, Norman RJ, Seamark RF, Robertson SA. 1994. Rat ovary produces cytokines during ovulation. Biol. Reprod. 50:88-94
68. Broockfor FR, Schwarz LK. 1991. Effects of interleukin-6, interleukin-2, and tumor necrosis factor α on transferrin release from sertoli cells in culture. Endocrinology 129:256-62
69. Kauma SW, Herman K, Wang Y, Walsh SW. 1993. Differential mRNA expression and production of interleukin-6 in placental trophoblast and villous core compartments. Am. J. Reprod. Med. 30:131-35
70. Carr DJ. 1992. Neuroendocrine peptide receptors on cells of the immune system. Chem. Immunol. 52:84-105
71. Kendall MD. 1991. Functional anatomy of the thymic microenvironment. J. Anat. 177:1-29
72. De Leeuw FE, Jansen GH, Batanero E, Van Wichen DF, Huber J, Schuurman HJ. 1992. The neural and neuroendocrine component of the human thymus 1. Nerve-like structures. Brain Behav. Immun. 6:234-48
73. Batanero E, De Leeuw FE, Jansen GH, Van Wichen DF, Huber J, Schuurman HJ. 1992. The neural and neuro-endocrine component of the human thymus. II. Hormone reactivity. Brain Behav. Immun. 6:249-64
74. Sabharwal P, Varma S, Malarkey WB. 1992. Human thymocytes secrete luteinizing hormone: An autocrine regulator of T-cell proliferation. Biochem. Biophys. Res. Comm. 187:1187-92
75. Martin-Fontecha A, Broekjuizen R, De Heer C, Zapata A, Schuurman H-J. 1993. The neuro-endocrine component of the rat thymus: studies on cultured thymic fragments before and after transplantation in congenitally athymic rats. Brain Behav. Immunity 7:1-15
76. Maier CC, Marchetti B, LeBoeuf RD. 1992. Thymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA. Cell. Molec. Neurobiol. 12:447-54
77. Aguila MC, Dees WL, Haensly WE. 1991. Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc. Nail Acad. Sci. USA 88:11485-89
78. Kelley KW, Arkins S, Li YM. 1992. Growth hormone prolactin, and insulin-like growth factors: New jobs for old players. Brain Behav. Immun. 6:317-26
79. Kao TL, Harbour DV, Meyer WJ III. 1992. Immunoreactive growth hormone production by cultured lymphocytes. Ann. N.Y. Acad Sci. 650:179-81
80. Binder G, Revskoy S, Gupta D. 1994. In vivo growth hormone expression in neonatal rat thymus and bone marrow. J. Endocrinol, 140:137-43
81. Muglia LJ, Jenkins NA, Gilbert DJ, Copeland NG, Majzoub JA. 1994. Expression of the mouse corticotropin-releasing hormone gene in vivo and targeted inactivation in embryonic stem cells. J. Clin. Invest. 93:2066-72
82. Ekman R, Servenius B, Castro MG, Lowry PJ, Cederlund AS, Bergman O, Sjogren HO. 1993. Biosynthesis of corticotropin-releasing hormone in human T lymphocytes. J. Neuroimmunol. 44:7-13
83. Aird F, Clevenger CV, Prystowsky MB, Redel E. 1993. Corticotropin-releasing factor mRNA in rat thymus and spleen. Proc. Natl Acad. Sci. USA 90:7104-8
84. Redel E. 1992. Immuno-reactive and bioactive corticotropin-releasing factor in rat thymus. Neuroendocrinology 55:115-18
85. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL, Chrousos GP. 1991. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254:421-23
86. Crofford LJ, Sano H, Karalis K, Webster EL, Goldmuntz EA, Chrousos GP, Wilder RL. 1992. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J. Clin. Invest. 90:2555-64
87. Crofford LJ, Sano H, Karalis K, Friedman TC, Epps HR, Remmers EF, Mathern P, Chrousos GP, Wilder RL. 1993. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J. Immunol. 151:1587-96
88. De Souza EB, Grigoriadis DE, Webster EL. 1991. Role of brain, pituitary and spleen corticotropin-releasing factor receptors in the stress response. Methods Achieve. Exp. Pathol. 14:23-44
89. Singh VK, Leu SJ. 1993. Corticotropinreleasing factor-induced production of cyclic AMP by human peripheral blood immunocytes. Immunol. Letters 35: 239-45
90. Angioni S, Petraglia F, Gallinelli A, Cossarizza A, Franceschi C, Michela M, Genazzani A, Surico N, Genazani A. 1993. Corticotropin-releasing hormone modulates cytokines release in cultured human peripheral blood mononuclear cells. Life Sci. 53:1735-42
91. Reder AT. 1992. Regulation of production of adrenocorticotropin-like proteins in human mononuclear cells. Immunology 77:436-42
92. Hagan PM, Poole S, Bristow AF. 1993. Corticotropin-releasing factor as a mediator of the acute-phase response in rats, mice and rabbits. J. Endocrinology 136:207-16
93. Genedani S, Bernardi M, Baldini MG, Bertolini A. 1992. Influence of CRF and α-MSH on the migration of human monocytes in vitro. Neuropeptides 23:99-102
94. Koshida H, Kotake Y. 1994. Corticotropin-releasing hormone enhances the superoxide anion production of rabbit peritoneal macrophages simulated with N-formyl-methionyl-leucyl-phenyalanine. Life Sci. 34:539-43
95. Singh VK. 1989. Stimulatory effects of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression. J. Neuroimmunol. 23:257-62
96. McGillis JP, Park A, Rubin-Fletter P, Turek C, Dallman MF, Payan DG. 1989. Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor. J. Neurosci. Res. 23:346-52
97. Irwin M, Vale W, Rivier C. 1990. Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity. Endocrinology 126:2837-44
98. Jain R, Zwickler D, Hollander C. 1991. Corticotropin releasing factor modulates the immune response to stress in the rat. Endocrinology 128:1329-36
99. Nabriski D, Saperstein AD, Brand H, Jain R, Zwickler D, Hutchinson B, Rosenzweig S, Hollander CS, Audhya T. 1991. Role of corticotropin-releasing factor in immunosuppression. Trans. Assoc. Am. Phys. 104:238-47
100. Hagan P, Poole S, Bristow AF. 1992. Immunosuppressive activity of corticotropin-releasing factor. Inhibition of interleukin-1 and interleukin-6 production by human mononuclear cells. Biochem. J. 281:251-54
101. Irwin M. 1993. Brain corticotropin-releasing hormone and interleukin-1 β-induced suppression of specific antibody production. Endocrinology 133:1352-60
102. Thomas HA, Ling N, Wei ET. 1993. CRF and related peptides as anti-inflammatory agonists. Ann. N.Y. Acad. Sci. 29:219-28
103. Jefferies WM. 1991. Cortisol and immunity. Med. Hypothesis 34:198-208
104. Munck A, Guyre PM, Holbrook N. 1984. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5:25-44
105. Nieto MA, Gonzalez F, Gambon F, Diaz-Espada F, Lopez-Rivas A. 1992. Apoptosis in human thymocytes after treatment with glucocorticoids. Clin. Exp. Immunol. 88:341-44
106. Iwata M, Hanaloka S, Sato K. 1991. Rescue of thymocytes and T cell hybridomas from glucocorticoid induced apoptosis by stimulation via the T cell receptor/CD3 complex: possible in vitro model for positive selection of the T cell repertoire. Eur. J. Immunol. 21:643-48
107. Compton MM, Johnson LR, Gibbs PS. 1991. Activation of thymocyte deoxyribonucleic acid degradation by endogenous gluocorticoids. Poultry Sci. 70:521-29
108. Gruber J, Sgonc R. Hu YH, Beng H, Wick G. 1994. Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur. J. Immunol. 24:1115-21
109. Vacchia MS, Papadopoulos V, Ashwell JD. 1993. Steroid production in the thymus: implications for thymocyte selection. J. Exp. Med. 179:1835-46
110. Iseki R, Mukai M, Iwata M. 1991. Regulation of T lymphocyte apoptosis. Signals for the antagonism between activation and glucocorticoid induced death. J. Immunol. 147:4286-92
111. Gonzalo JA, Gonzalo-Garcia A, Martinez AC, Kroemer G. 1993. Glucocorticoid-mediated control of the clonal deletion and activation of peripheral T cells in vivo. J. Exp. Med. 248:1239-46
112. Vacca A, Felli MP, Farina AR, Martinotti S, Maroder M, Screpanti I, Meco D, Petrangeli ELF, Gulino A. 1992. Glucocorticoid receptor mediated suppression of the interleukin-2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP 1 enhancer elements. J. Exp. Med. 175:637-46
113. Daynes RA, Araneo BA. 1989. Contrasting effects of glucocorticoids on the capacity of T cells to produce growth factors interleukin-2 and interleukin-4. Eur. J. Immunol. 19:2319-25
114. Zubiaga AM, Munoz E, Huber BT. 1992. II-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid induced apoptosis. J. Immunol. 149:107-12
115. Ayaniar Batuman O, Ferrero AP, Diaz A, Jimenez SA. 1991. Regulation of transforming growth factor-β1 gene expression by glucocorticoids in normal human T lymphocytes. J. Clin. Invest. 88:1574-80
116. Spencer RL, Miller AH, Moday H, Stein M, McEwen BS. 1993. Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues. Endocrinology 133:1941-950
117. Costa O, Mulchahey J, Blalock JE. 1990. Structure and function of luteinizing hormone releasing hormone (LHRH) receptors on lymphocytes. Prog. Neuroendocrinol. Immunol. 3:35-60
118. Marchetti B, Guarrcello V, Moral MC, Bartoioni G, Raiti F, Palumbo G, Garinella Z, Cordaro S, Scapagnini U. 1989. LHRH agonist restoration of age associated decline of thymus weight. Thymic LHRH receptors and thymocyte proliferative capacity. Endocrinology 125:1037-45
119. Rao LV, Cleveland RP, Ataya KM. 1993. Alterations in thymic and bone marrow lymphocyte subpopulations in GNRH treated prepubertal female mice. J. Reprod. Immunol. 25:167-84
120. Morale MC, Batticane N, Bartoioni G, Guarcello V, Farinella Z, Galasso G, Marchetti B. 1991. Blockade of central and peripheral luteinizing hormone-releasing hormone (LHRH) receptors in neonatal rats with a potent LHRH-antagonist inhibits the morphofunctional development of the thymus and maturation of the cell-mediated and humoral immune responses. Endocrinology 128:1073-85
121. Jacobson JD, Nisula BC, Steinberg AD. 1994. Modulation of the expression of murine lupus by gonadotropin-releasing hormone analogs. Endocrinology 134:2516-23
122. Screpanti I, Meco D, Morrone S, Gulino A, Mathieson BJ, Frati L. 1991. In vivo modulation of the distribution of thymocyte subsets: effects of estrogen on expression of different T cell receptor V β gene families in CD4-, CD8- thymocytes. Cell. Immunol. 134:414-26
123. Leposavic G, Micic M. 1992. Testosterone binding sites in the rat thymus during late embryonal and postnatal period. Thymus 38:77-88
124. Olsen NJ, Zhou P, Ong H. 1993. Testosterone induces expression of transforming growth factor-β, in the murine thymus. J. Steroid Biochem. Mol. Biol. 45:327-32
125. Weksler ME. 1993. Immune senescence and adrenal steroids: immune dysregulation and the action of dehydroepiandrosterone (DHEA) in old animals. Eur. J. Clin. Pharmacol. 45:521-23
126. Daynes R A, Araneo BA, Ershlergrowth WB, Maloney C, Li GZ, Ryu SY. 1993. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J. Immunol. 150:5219-30
127. Suzuki T, Suzuki N, Daynes RA, Engleman EG. 1991. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin. Immunol. Immunopathol. 61:202-11
128. Meikle AW, Dorchuck RW, Araneo BA, Stringham JD, Evans TG, Spruance SL, Daynes RA. 1992. The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J. Steroid Biochem. Mol. Biol. 42:293-304
129. Blauer KL, Poth M, Rogers WM, Bernton EW. 1991. Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology 129:3174-79
130. Lucas JA, Ahmed SA, Casey ML, Mac-Donald PC. 1985. Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone. J. Clin. Invest. 75:2091-93
131. Gala RR. 1991. Prolactin and growth hormone in the regulation of the immune system. Proc. Soc. Exp. Biol. Med. 198:513-27
132. Erf GF. 1993. Immune development in young-adult CRF-hyt mice is affected by congenital and maternal hypothyroidism. Proc. Soc. Exp. Biol. Med. 204:40-48
133. Johnson BE, Marsh JA, King DB. 1992. Effect of triiodothyronine on the expression of T cell markers and immune function in thyroidectomized white leghorn chickens. Proc. Soc. Exp. Biol. Med 199:104-13
134. Murphy WJ, Durum SK, Longo DL. 1992. Human growth hormone promotes engraftment of murine or human T cells in severe combined immunodeficient mice. Proc. Natl. Acad. Sci. USA 89:4481-85
135. Villanua MA, Szary A, Bartke A, Esquifina Al. 1992. Changes in lymphoid organs of Ames dwarf mice after treatment with growth hormone, prolactin or ectopic pituitary transplants. J. Endocrinol. Invest. 15:587-95
136. Cross RJ, Bryson JS, Roszman TL. 1992. Immunologic disparity in the hypopituitary dwarf mouse. J. Immunol. 148:1347-52
137. Murphy WJ, Durum SK, Longo DA. 1992. Neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. J. Immunol. 149:3851-57.
138. Knyszynski A, Adler-Kunin S, Globerson A. 1992. Effects of growth hormone on thymocyte development from progenitor cells in the bone marrow. Brain Behav. Immun. 6:327-40
139. Murphy WJ, Durum SK, Anver MR. Longo DL. 1992. Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J mice. J. Immunol. 148:3799-3805
140. Wit JM, Kooijman R, Rijkers GT, Zegers BJM. 1993. Immunological findings in growth hormone-treated patients. Horm. Res. 39:107-10
141. Murphy WJ, Durum SK, Longo DL. 1993. Differential effects of growth hormone and prolactin on murine T cell development and function. J. Exp. Med. 178:231-36
142. Guarcello V, Weigent DA, Blalock JE. 1991. Growth hormone releasing hormone receptors on thymocytes and splenocytes from rats. Cell. Immunol. 136:291-302
143. Sabharwal P, Glaser R, Lafuse W, Varma S, Liu A, Arkins S, Kooijman R, Kutz L, Kelley KW, Malarkey WB. 1992. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation. Proc. Natl. Acad. Sci. USA 89:7713-16
144. Delhase M, Vergani P, Malur A, Hooghe-Peters EL, Hooghe RJ. 1993. The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid tissues. Eur. J. Immunol. 23:951-55
145. Gala RR, Shevach EM. 1994. Evidence for the release of a prolactin-like substance by mouse lymphocytes and macrophages. Proc. Soc. Exp. Biol. Med. 205:12-19
146. Peele ME, Carr FE, Baker JR Jr, Wartofsky L, Burman KD. 1993. TSH β subunit gene expression in human lymphocytes. Am. J. Med. Sci. 305:1-7
147. Dardenne M, Kelly PA, Bach JF, 1991. Identification of functional activity of prolactin receptors in thymic epithelial cells. Proc. Natl. Acad. Sci. USA 88:9700-4
148. Timsit J, Savino W, Safieh B. 1992. Growth hormone and insulin-like growth factor-1 stimulate hormonal function and proliferation of thymic epithelial cells. J. Clin Endocrinol. Metab. 75:183-88
149. Wilder RL. 1993. Corticotropin releasing hormone and the hypothalamic-pituitary-adrenal axis in the regulation of inflammatory arthritis. Agents Actions 41:3-9
150. Griffin AC, Whitacre CC. 1991. Sex and stain differences in the circadian rhythm fluctuation of endocrine and immune function in the rat: implications for rodent models of autoimmune disease. J. Neuroimmunol. 35:53-64
151. Dhabhar FS, McEwen BS, Spencer RL. 1993. Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels - a comparison between Sprague-Dawley, Fischer 344 and Lewis rats. Brain Res. 616:89-98
152. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW. Wilder RL. 1989. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proc. Null. Acad. Sci. USA 86:2374-78
153. Sternberg EM, Young WS III, Bernardini R, Calogero A, Chrousos GP, Gold PW, Wilder RL. 1989. A central nervous system defect in corticotropin releasing hormone biosynthesis is associated with susceptibility to streptococcal cell wall arthritis in Lewis rats. Proc. Natl. Acad. Sci. USA 86:4771-75
154. Calogero AE, Sternberg EM, Bagby G, Smith C, Young WS III, Bernardini R, Aksentijevich S, Wilder RL, Gold PW, Chrousos GP. 1992. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats. In vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. Neuroendocrinology 55:600-8
155. Patchev VK, Kalogeras LJ, Zelazowski P, Wilder RL, Chrousos GP. 1992. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine-vasopressin in inflammatory disease-prone, hypothalamic CRH-deficient Lewis rats. Endocrinology 131: 1453-57
156. Patchev VK, Mastorakos G, Brady LS, Redwine J, Wilder RL, Chrousos GP. 1993. Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory diseases. Neuroendocrinology 58:106-10
157. Macphee IA, Antoni FA, Mason DW. 1989. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169:431-45
158. Mason DW, Macphee IA, Antoni FA. 1990. The role of neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology 70:1-5
159. Mason D. 1991. Genetic variation in the stress response: susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease. Immunol. Today 12:57-60
160. Sternberg EM, Glowa JR, Smith MA, Calogero AE, Listwak SJ, Aksentijevich S, Chrousos GP, Wilder RL, Gold PW. 1992. Corticotropin releasing hormone related behavioral and neuroendocrine responses in Lewis and Fischer rats. Brain Res. 570:64-60
161. Griffin AC, Lo WC, Wolny AC, Whitacre CC, 1993. Suppression of experimental autoimmune encephalomyelitis by restraint stress: sex differences. J. Neuroimmunol 44:103-16
162. Kuroda Y, Mon T, Hori T. 1994. Restraint stress suppresses experimental allergic encephalomyelitis in Lewis rats. Brain Res. Bull. 34:15-17
163. Leonard JP, Mackenzie FJ, Patel HA, Cuzner ML. 1991. Hypothalamic nor-adrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis. Brain Behav. Immun. 5:328-38
164. Crabbe JC, Belknap JK, Buck KJ. 1994. Genetic animal models of alcohol and drug abuse. Science 264:1715-23
165. Wick G, Hu Y, Gruber J, Kuehr T, Wozak E, Hala K. 1993. The role of modulatory factors in the multifaceted pathogenesis of autoimmune thyroiditis. Int. Rev. Immunol. 9:77-89
166. Hu Y, Dietrich H, Herold M, Heinrich PC, Wick G. 1993. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Int. Arch. Allergy Immunol. 102:232-41
167. Chesnokova VM, Chukhlib VL, Ignat'eva EV, Ivanova LN. 1991. The possible involvement of glucocorticoids in the development of genetically determined autoimmune pathology in NZB mice. Biomed. Sci. 2:557-61
168. Sato EH, Sullivan DA. 1994. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjogren's syndrome. Invest. Ophthalmol. Vis. Sci. 35:2632-42
169. Jevnikar AM, Singer GG, Brennan DC, Xu HW, Kelley VR. 1992. Dexamethasone prevents autoimmune nephritis and reduces renal expression of la but not costimulatory signals. Am. J. Pathol. 141:743-51
170. Lannes-Vieira J, Dardenne M, Savino W. 1991. Extracellular matrix components of the mouse thymus microenvironment: ontogenetic studies and modulation by glucocorticoid hormones. J. Histochem. Cytochem. 39:1539-46
171. Keisler LW, Vom Saal FS, Keisler DH, Walker SE. 1991. Hormonal manipulation of the prenatal environment alters reproductive morphology and increases longevity in autoimmune NZB/W mice. Biol. Reprod. 44:707-16
172. Sato EH, Ariga H, Sullivan DA. 1992. Impact of androgen therapy in Sjogren's syndrome: hormonal influence on lymphocyte populations and la expression in lacrimal glands of MRL/Mp-1pr/1pr mice. Invest. Ophthalmol. Vis. Sci. 33:2537-45
173. Seggev JS, Sunderrajan EV, Palomo T, McKenzie WN, Braun SR, O'Sullivan
174. Carlsten H, Nilsson H, Jonsson R, Backman K, Holmdahl R, Tarkowski A. 1992 Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialoadenitis in autoimmune MRL lpr/lpr mice. Cell. Immunol. 144:190-202
175. Carlsten H, Tarkowski A. 1993. Histocompatibility complex gene products and exposure to oestrogen: Two independent disease accelerating factors in murine lupus. Scand. J. Immunol. 38:341-47
176. Trooster WJ, Teelken AW, Kampinga J, Loof JG, Nieuwenhuis P, Minderhoud JM. 1993. Suppression of acute experimental allergic encephalomyelitis by synthetic sex hormone 17- α ethinylestradiol: an immunological study in the Lewis rat. Int. Arch. Allergy Immunol. 102:133-40
177. Jansson L, Mattsson A, Mattsson R. Holmdahl R. 1990. Estrogen induced suppression of collagen arthritis. V. Physiological level estrogen in DBA/1 mice is therapeutic on established arthritis, suppresses anti-collagen II T-cell dependent immunity and stimulates polyclonal B-cell activity. J. Autoimmun. 3:257-70
178. Holmdahl R. 1989. Estrogen exaggerates lupus but suppresses T-cell-dependent-autoimmune disease: an hypothesis. J. Autoimmun. 2:651-56
179. Greenstein BD, Dhaher YY, Bridges E de F, Kese G, Khamashta MA, Etherington J, Greenstein AS, Coates PJ, Hall PA, Hughes GR. 1993. Effects of an aromatase inhibitor on thymus and kidney and on oestrogen receptors in female MRL/MP-lpr/lpr mice. Lupus 2:221-25
180. McMurray R, Keisler D. Kanuckel K, Izui S, Walker SE. 1991. Prolactin influences autoimmune disease activity in the female B/W mouse. J. Immunol. 147:3780-87
181. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. 1993. Effects of parturition, suckling, and pseudopregnancy on parameters of systemic lupus erythematosus. J. Rheumatol. 20:1143-51
182. Fitzpatrick F. Christeff N, Durant S, Dardenne M, Nunez EA, Homo-Delarche F. 1992. Glucocorticoids in the nonobese (NOD) mouse: basal serum levels, effect of endocrine manipulation and immobilization stress. Life Sci. 50:1063-69
183. Hawkins T, Gala R, Dunbar JC. 1993. The effect of neonatal sex hormone manipulation on the incidence of diabetes in nonobese diabetic mice. proc, Soc. Exp. Biol. Med. 1993:201-5
184. Leijon K, Hammarstrom B, Holmberg D. 1994. Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. Int. Immunol. 6:339-45
185. Hammond GL, Smith CL. 1991. An amino acid substitution in BioBreeding rat corticosteroid binding globulin results in reduced steroid binding affinity. J. Biol. Chem. 266:18555-59
186. Neeck G, Federlin K, Graif V, Rusch D, Schmidt KL. 1990. Adrenal secretion of cortisol in patients with rheumatoid arthritis. J. Rheumatol. 17:24-29
187. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. 1992. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum. 35:1281-88
188. Cash JM, Crofford LJ, Galluci WT, Sternberg EM, Gold PW, Chrousos GP, Wilder RL. 1992. Pituitary-adrenal axis respon-siveness to ovine corticotropin releasing hormone in patients with rheumatoid arthritis treated with low dose prednisone. J. Rheumatol. 19:1692-96
189. van den Brink HR, Blankenstein MA, Koppeschaar HP, Bijlsma JW. 1993. Influence of disease activity on steroid hormone levels in peripheral blood of patients with rheumatoid arthritis. Clin. Exp. Rheumatol 11:649-52
190. Morand EF, Jefferiss CM, Dixey J, Mitra D, Goulding NJ. 1994. Impaired glucocorticoid induction of mononuclear leukocyte lipocortin-1 in rheumatoid arthritis. Arthritis Rheum. 37:207-11
191. Podgorski MR, Goulding NJ, Hall NK, Flower RJ, Maddison PJ. 1992. Autoantibodies to lipocortin-1 are associated with impaired glucocorticoid responsiveness in rheumatoid arthritis. J. Rheumatol. 19:1668-71
192. Schlaghecke R, Kornely E, Wollenhaupt J, Specker C. 1992. Glucocorticoid receptors in rheumatoid arthritis. Arthritis Rheum. 35:740-44
193. Zoukos Y, Leonard JP, Thomaides T, Thompson AJ, Cuzner ML. 1992. Beta adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1. Ann. Neurol. 31:657-62
194. Deighton CM, Watson MJ, Walker DJ. 1992. Sex hormones in postmenopausal HLA-identical rheumatoid arthritis discordant sibling pairs. J. Rheumatol 19:1663-67
195. Hall GM, Perry LA, Spector TD. 1993. Depressed levels of dehydroepiandosterone sulphate in postmenopausal women with rheumatoid arthritis but no relation with axial bone density. Ann. Rheum. Dis. 52:211-14
196. James WH. 1993. Sex ratios and hormones in HLA related diseases. Ann. Rheum. Dis. 50:401-14
197. Cutolo M, Accardo S. 1992. Sex hormones, HLA and rheumatoid arthritis. J. Androl. 13:87-92
198. Cutolo M, Balleari E, Giusti M, Intra E, Accardo S. 1991. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum. 34:1-5
199. Bijlsma JW, van den Brink HR. 1992. Estrogens and rheumatoid arthritis. Am. J. Reprod. Immunol. 28:231-34
200. van den Brink HR, Lems WF, van Everdingen AA, Bijlsma JW. 1993. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann. Rheum. Dis. 52:302-5
201. Daniels M, Huskisson EC, Spector TD. 1994. A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann. Rheum. Dis. 53:112-16
202. Chikanza IC, Petrou P, Chrousos GP, Kingsley G, Panayi GS. 1993. Excessive and dysregulated secretion of prolactin in rheumatoid arthritis. Immunopathogenetic and therapeutic implications. Br. J. Rheumatol. 32:445-48
203. Hedman M, Nilsson E, de la Toore B. 1992. Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis. Clin. Exp. Rheumatol. 10:25-30
204. Lahita RG. 1992. The importance of estrogens in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 63:17-18
205. Folomeev M, Dougados M, Beaune J, Kouyoumdjian JC, Nahoul K, Amor B, Alekberova Z. 1992. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1:191-95
206. Sequeira JF, Keser G, Greenstein B. Wheeler MJ, Duarte PC, Khamashta MA, Hughes GR, 1993. Systemic lupus erythematosus: sex hormones in male patients. Lupus 2:315-17
207. Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR. 1992. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am. J. Med. Sci. 303:222-26
208. Petri M. 1994. Systemic lupus erythematosus and pregnancy. Rheum. Dis. Clin. North Am. 20:87-118
209. Jara-Quezada L, Graef A, Lavalle C. 1991. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J. Rheumatol. 18:349-53
210. Takasu N, Komiya I, Nagasawa Y, Asawa T, Yamada T. 1990. Exacerbation of autoimmune thyroid dysfunction after unilateral adrenalectomy in patients with Cushing's syndrome due to an adrenocortical adenoma. New Engl. J. Med. 322:1708-12
211. Takasu N, Ohara N, Yamada T. Komiya I. 1993. Development of autoimmune thyroid dysfunction after bilateral adrenalectomy in a patient with Carney's complex and after removal of ACTH-producing pituitary adenoma in a patient with Cushing's diseases. J. Endocrinol Invest. 16:691-702
212. Wegmann TG, Lin H, Guilbert L, Mosmann TR. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phe-nomenon? Immunol. Today 14:353-56
213. Shinomiya N, Tsuru S, Tsugita M, Katsura Y, Takemura T, Rokutada M, Nomota K. 1991. Thymic depletion in pregnancy: kinetics of thymocytes and immunologic capacities of the hosts. J. Clin. Lab. Immunol. 34:11-22
214. Medina K, Smithson G, Kincade PW. 1993. Suppression of B lymphopoiesis during normal pregnancy. J. Exp. Med. 178:1507-15
215. Dudley DJ, Chen CL, Mitchell MD, Daynes RA, Araneo BA. 1993. Adaptive immune responses during murine pregnancy-induced regulation of lymphokine production by activated T lymphocytes. Am. J. Obstet. Gynecol. 168:1155-63
216. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. 1993. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 151:4562-73
217. Delassus S, Coutinho GC, Saucier C, Darche S, Kourilsky P. 1994. Differential cytokine expression in maternal blood and placenta during murine gestation. J. Immunol. 152:2411-20
218. Berczi I. 1993. Prolactin, pregnancy and autoimmune disease. (Editorial) J. Rheumatol. 20:1095-1100
219. Brennan P, Silman A. 1994. Breast-7 feeding and the onset of rheumatoid arthritis. Arthritis Rheum. 37:808-13
220. Konttinen YT, Kemppinen P, Segerberg M, Hukkanen M, Rees R, Santavirta S, Sorsa T, Pertovaara A, Polak JM. 1994. Review: Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum. 37:965-82